Adjunct therapy for type 1 diabetes mellitus

被引：0
|
作者：
Harold E. Lebovitz
机构：
[1] State University of New York Health Science Center at Brooklyn,Department of Medicine, Division of Endocrinology
来源：
Nature Reviews Endocrinology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Insulin replacement therapy in type 1 diabetes mellitus (T1DM) leads to peripheral hyperinsulinemia, which is associated with potentially serious metabolic complications, such as increased hypoglycemia, weight gain and postprandial hyperglucagonemia. This Review discusses adjunctive therapies to minimize these complications in patients with T1DM, with a focus on the islet amyloid polypeptide analog pramlintide.
引用
收藏
页码：326 / 334
页数：8
相关论文
共 50 条
  • [1] Adjunct therapy for type 1 diabetes mellitus
    Lebovitz, Harold E.
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (06) : 326 - 334
  • [2] Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
    Tamez, Hector E.
    Tamez, Alejandra L.
    Garza, Lucas A.
    Hernandez, Mayra I.
    Polanco, Ana C.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2015, 14
  • [3] Dapagliflozin as an adjunct therapy to insulin in the treatment of patients with type 1 diabetes mellitus
    Hector E. Tamez
    Alejandra L. Tamez
    Lucas A. Garza
    Mayra I. Hernandez
    Ana C. Polanco
    Journal of Diabetes & Metabolic Disorders, 14 (1):
  • [4] Efficacy of dapagliflozin as an adjunct therapy in patients with inadequately controlled type 1 diabetes mellitus
    Van den Mooter, Laura
    Caerels, Simon
    Mathieu, Chantal
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (06) : 617 - 622
  • [5] SGLT inhibitor adjunct therapy in type 1 diabetes
    McCrimmon, Rory J.
    Henry, Robert R.
    DIABETOLOGIA, 2018, 61 (10) : 2126 - 2133
  • [6] SGLT inhibitor adjunct therapy in type 1 diabetes
    Rory J. McCrimmon
    Robert R. Henry
    Diabetologia, 2018, 61 : 2126 - 2133
  • [7] THE IMPACT OF ADJUNCT DAPAGLIFLOZIN ON TREATMENT SATISFACTION IN TYPE 1 DIABETES MELLITUS
    Gordon, J.
    Beresford-Hulme, L.
    Bennett, H.
    Tank, A.
    Edmonds, C.
    McEwan, P.
    VALUE IN HEALTH, 2019, 22 : S590 - S590
  • [8] Insulin therapy for diabetes mellitus type 1
    Dreyer, M.
    DIABETOLOGE, 2014, 10 (06): : 453 - 459
  • [9] Immune therapy in type 1 diabetes mellitus
    Åke Lernmark
    Helena Elding Larsson
    Nature Reviews Endocrinology, 2013, 9 : 92 - 103
  • [10] Adjuvant therapy in type 1 diabetes mellitus
    Cichocka, Edyta
    Maj-Podsiadlo, Anna
    Gumprecht, Janusz
    ENDOKRYNOLOGIA POLSKA, 2021, 72 (01) : 87 - 88
12345